News
ASRT
23.50
0.00%
0.00
Assertio Completes Merger with Zydus, Delists from Nasdaq
TipRanks · 06/16 21:28
Assertio completes merger with Zydus Lifesciences at $23.5 per share cash
PUBT · 06/16 20:30
ASSERTIO ANNOUNCES COMPLETION OF MERGER WITH ZYDUS LIFESCIENCES AND FUNDAMENTAL CHANGE AND MAKE-WHOLE FUNDAMENTAL CHANGE RELATING TO ITS OUTSTANDING 6.50% CONVERTIBLE SENIOR NOTES DUE 2027
Reuters · 06/16 20:30
NASDAQ TRADE HALT <ASRT.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 06/15 23:50
Weekly Report: what happened at ASRT last week (0608-0612)?
Weekly Report · 06/15 10:27
Weekly Report: what happened at ASRT last week (0601-0605)?
Weekly Report · 06/08 10:23
Celularity names Rick Gonzalez chief commercial officer
PUBT · 06/03 12:06
Weekly Report: what happened at ASRT last week (0525-0529)?
Weekly Report · 06/01 10:28
Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit
Seeking Alpha · 05/26 07:56
Weekly Report: what happened at ASRT last week (0518-0522)?
Weekly Report · 05/25 10:31
Assertio Therapeutics to be acquired by Zydus Worldwide
TipRanks · 05/18 14:37
Assertio agrees to be acquired by Zydus Worldwide for $23.5 per share cash
PUBT · 05/18 13:24
Weekly Report: what happened at ASRT last week (0511-0515)?
Weekly Report · 05/18 10:31
Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Therapeutics (ORKA)
TipRanks · 05/14 13:21
BUZZ-India's Zydus Lifesciences hits six-month peak on buyback plan
Reuters · 05/14 06:08
Assertio Holdings Is Maintained at Hold by Lake Street
Dow Jones · 05/13 20:32
Assertio Holdings Price Target Raised to $23.50/Share From $21.80 by Lake Street
Dow Jones · 05/13 20:32
Lake Street Maintains Hold on Assertio Hldgs, Raises Price Target to $23.5
Benzinga · 05/13 20:23
BUZZ-U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
Reuters · 05/13 17:36
Assertio to be acquired by Zydus Worldwide DMCC for $23.50 per share
TipRanks · 05/13 16:51
More
Webull provides a variety of real-time ASRT stock news. You can receive the latest news about Assertio Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASRT
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.